04.19.16
Solvay Aroma Performance, one of the worldwide leaders in diphenol and derivatives intermediates, plans to build an additional production capacity of Hydroquinone (HQ) in China starting-up in 2018. This investment will be based on an innovative and environmental friendly technology.
In addition, the Global Business Unit will extend its worldwide Methyl hydroquinone (MEHQ also referred as PMP – paramethoxyphenol) capacity. Both projects will support Solvay captive needs as well as the growth of HQ and MEHQ markets, particularly in Asia.
“This decision will strengthen the company leading position in growing markets like Monomer inhibition with a full range of solutions including PTZ coming from Cytec acquisition, Specialty polymers and Coatings applications as well as Food & Feed antioxidants on which we are positioning ourselves” said Dominique Rage, President of the GBU. “This major capacity increase enhances our reliability towards our customers and will allow for new growth opportunities” he adds.
In addition, the Global Business Unit will extend its worldwide Methyl hydroquinone (MEHQ also referred as PMP – paramethoxyphenol) capacity. Both projects will support Solvay captive needs as well as the growth of HQ and MEHQ markets, particularly in Asia.
“This decision will strengthen the company leading position in growing markets like Monomer inhibition with a full range of solutions including PTZ coming from Cytec acquisition, Specialty polymers and Coatings applications as well as Food & Feed antioxidants on which we are positioning ourselves” said Dominique Rage, President of the GBU. “This major capacity increase enhances our reliability towards our customers and will allow for new growth opportunities” he adds.